In an adult with a transferrin saturation of 9%, what total dose of intravenous iron is recommended?

IV Iron Dosing for TSAT 9%

For an adult with transferrin saturation of 9%, administer 1000 mg of intravenous iron as a total dose infusion (or 100-125 mg weekly for 8-10 weeks), followed by maintenance dosing of 25-125 mg weekly to maintain TSAT >20%. 1

Initial Repletion Phase

With a TSAT of 9%, this patient has severe iron deficiency requiring aggressive repletion. The NKF-K/DOQI guidelines provide two evidence-based approaches:

Option 1: Total Dose Infusion (Preferred for efficiency)

• 500-1000 mg iron dextran as a single IV infusion after a 25 mg test dose 1
• Dilute in 250 mL normal saline, infuse over 1 hour
• Can be repeated as needed based on follow-up iron parameters
• Note: As of 2000, large single doses of iron gluconate were not recommended 1
• Newer formulations (ferric carboxymaltose, ferric derisomaltose) allow up to 1000-1500 mg single doses 2

Option 2: Divided Dosing Regimen

• 100-125 mg IV iron at each hemodialysis session for 8-10 doses (weekly if not on dialysis) 1
• Total cumulative dose: 800-1250 mg over 8-10 weeks
• This provides 250-1000 mg within 12 weeks, which is the acceptable range 1

Clinical Context Matters

The specific approach depends on your patient population:

For hemodialysis patients: Most will require ongoing IV iron on a regular basis to maintain adequate iron stores with erythropoietin therapy 1. The divided dosing approach (100-125 mg per dialysis session) integrates well into routine care.

For CKD/peritoneal dialysis patients not on hemodialysis: Total dose infusion (500-1000 mg) is preferred since these patients may not maintain adequate iron status with oral iron and benefit from less frequent dosing 1.

For heart failure patients: Recent evidence supports IV iron for functional iron deficiency (ferritin 100-300 ng/mL with TSAT <20%) 3. While your patient's TSAT of 9% indicates more severe deficiency, the same IV repletion principles apply.

Monitoring and Reassessment

After initial repletion:

• Wait 2 weeks before checking iron parameters if you gave ≥1000 mg as a single dose 1
• Wait 7+ days if you gave 200-500 mg 1
• No waiting needed if giving ≤125 mg weekly doses 1

If TSAT remains <20% after the initial course, repeat another 8-10 week course of 100-125 mg weekly 1.

Maintenance Phase

Once TSAT reaches >20%:

• 25-125 mg IV iron weekly to maintain adequate iron stores 1
• The goal is providing 250-1000 mg within any 12-week period 1
• Monitor TSAT and ferritin every 3 months 1

Safety Considerations

Upper limits to avoid iron overload:

• Hold IV iron if TSAT >50% or ferritin >800 ng/mL 1
• Resume at reduced dose (one-third to one-half) when values fall below these thresholds 1

Distinguishing functional iron deficiency from inflammatory block: If TSAT <20% but ferritin is 100-700 ng/mL and clinical picture is unclear, give 50-125 mg IV iron weekly for 8-10 doses as a therapeutic trial 1. If no erythropoietic response occurs, suspect inflammatory block and discontinue iron until inflammation resolves 1.

Formulation-Specific Dosing

Modern formulations allow more flexible dosing 2:

• Ferric carboxymaltose (FCM): Up to 1000 mg per dose
• Ferric derisomaltose (FDI): Up to 1500 mg (20 mg/kg) - only formulation with FDA-approved total dose infusion label
• Iron sucrose: Maximum 200 mg per dose (avoid large single infusions)

Common pitfall: Don't rely on oral iron for this patient. With TSAT of 9%, oral iron is inadequate and unlikely to achieve target hemoglobin/hematocrit, especially in dialysis patients 1. The evidence consistently shows IV iron superiority over oral supplementation for functional and absolute iron deficiency in these populations 4.